The novel approach of the medication represents a significant breakthrough in the care of the condition. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide173659.tokka-blog.com/42449180/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment